Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug development: try and try again.

Literature DB >> 25470198

Drug development: try and try again.

Megan Scudellari.

Abstract

Mesh：

Year: 2014 PMID： 25470198 DOI： 10.1038/516S4a

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

3 in total

1. Survival after sorafenib: expect the unexpected.

Authors: Richard S Finn
Journal: J Hepatol Date: 2013-11-09 Impact factor: 25.083

2. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.

Authors: Jeong Heo; Tony Reid; Leyo Ruo; Caroline J Breitbach; Steven Rose; Mark Bloomston; Mong Cho; Ho Yeong Lim; Hyun Cheol Chung; Chang Won Kim; James Burke; Riccardo Lencioni; Theresa Hickman; Anne Moon; Yeon Sook Lee; Mi Kyeong Kim; Manijeh Daneshmand; Kara Dubois; Lara Longpre; Minhtran Ngo; Cliona Rooney; John C Bell; Byung-Geon Rhee; Richard Patt; Tae-Ho Hwang; David H Kirn
Journal: Nat Med Date: 2013-02-10 Impact factor: 53.440

Review 3. Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors: Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal: Gut Date: 2014-02-14 Impact factor: 23.059

3 in total

16 in total

1. Functional Genetic Screening Enables Theranostic Molecular Imaging in Cancer.

Authors: Nicholas R Perkons; Omar Johnson; Gabrielle Pilla; Enri Profka; Michael Mercadante; Daniel Ackerman; Terence P F Gade
Journal: Clin Cancer Res Date: 2020-06-04 Impact factor: 12.531

2. Transcriptomics Associates Molecular Features with ¹⁸F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma.

Authors: Sandi A Kwee; Maarit Tiirikainen; Miles M Sato; Jared D Acoba; Runmin Wei; Wei Jia; Loic Le Marchand; Linda L Wong
Journal: Cancer Res Date: 2019-02-13 Impact factor: 12.701

3. Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model.

Authors: Kejin Zhou; Liem H Nguyen; Jason B Miller; Yunfeng Yan; Petra Kos; Hu Xiong; Lin Li; Jing Hao; Jonathan T Minnig; Hao Zhu; Daniel J Siegwart
Journal: Proc Natl Acad Sci U S A Date: 2016-01-04 Impact factor: 11.205

4. Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.

Authors: Jia Xin Yu; Amanda J Craig; Mary E Duffy; Carlos Villacorta-Martin; Verónica Miguela; Marina Ruiz de Galarreta; Alexander P Scopton; Lisa Silber; Andres Y Maldonado; Alexander Rialdi; Ernesto Guccione; Amaia Lujambio; Augusto Villanueva; Arvin C Dar
Journal: Mol Cancer Ther Date: 2019-06-18 Impact factor: 6.261

5. Molecular classification of hepatocellular carcinoma: potential therapeutic implications.

Authors: Nicolas Goossens; Xiaochen Sun; Yujin Hoshida
Journal: Hepat Oncol Date: 2015

Review 6. Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.

Authors: Amy P Chiu; Barbara R Tschida; Lilian H Lo; Branden S Moriarity; Dewi K Rowlands; David A Largaespada; Vincent W Keng
Journal: World J Gastroenterol Date: 2015-11-14 Impact factor: 5.742

10. Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.

Authors: Rajni Kant; Chia-Hung Yen; Chung-Kuang Lu; Ying-Chi Lin; Jih-Heng Li; Yi-Ming Arthur Chen
Journal: Int J Mol Sci Date: 2016-05-04 Impact factor: 5.923